Drug Shortage Report for CASPOFUNGIN FOR INJECTION
Report ID | 230495 |
Drug Identification Number | 02460947 |
Brand name | CASPOFUNGIN FOR INJECTION |
Common or Proper name | Caspofungin Acetate for Injection |
Company Name | JUNO PHARMACEUTICALS CORP. |
Market Status | MARKETED |
Active Ingredient(s) | CASPOFUNGIN |
Strength(s) | 50MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 50 mg - 1 vial per carton |
ATC code | J02AX |
ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2024-06-14 |
Actual start date | 2024-06-14 |
Estimated end date | 2024-08-31 |
Actual end date | 2024-08-06 |
Shortage status | Resolved |
Updated date | 2024-08-07 |
Company comments | Disruption of QC release testing schedule |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2233 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 2X7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-08-07 | English | Compare |
v7 | 2024-08-06 | French | Compare |
v6 | 2024-08-06 | English | Compare |
v5 | 2024-07-11 | French | Compare |
v4 | 2024-07-11 | English | Compare |
v3 | 2024-06-15 | English | Compare |
v2 | 2024-06-13 | French | Compare |
v1 | 2024-06-13 | English | Compare |
Showing 1 to 8 of 8